Summerset Group delivers Q2 update

Summerset Group saw first-half FY26 sales rise 17%, with resales up 26%.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Summerset Group Holdings Ltd (ASX: SNZ) share price is in focus after the company reported 448 occupation right sales in Q2 FY26, with resales up 26% and total first-half sales up 17% on last year.

Married elderly man and woman in love spending time together on bench on a phone, symbolising retirement.

Image source: Getty Images

What did Summerset Group report?

  • 448 occupation right sales in Q2 FY26 (221 new, 227 resales)
  • Q2 new sales unchanged from a year ago, but resales jumped 26%
  • First-half (1 Jan–30 Jun) total sales up 17% to 813
  • New sales up 12%, resales up 23% year-on-year for the first half
  • Strong sales at four newly opened village centres in NZ and Australia

What else do investors need to know?

Summerset opened four new village centre buildings in the first half of the year, with encouraging early demand. Occupancy rates at these centres ranged from 21% to 45%, highlighting good uptake across both Australian and New Zealand developments.

The group adjusted its New Zealand build rate in the wake of the Iran conflict, reducing its FY26 target to between 600–650 new homes but maintaining group deliveries within its forecast of 700–800, with 454 homes already delivered so far this year. Australian operations remain on track, with Cranbourne North open and Chirnside Park set to open later this year.

What did Summerset Group management say?

Summerset Chief Executive Scott Scoullar said:

Our total first half (1 Jan – 30 Jun) sales were up 17% on the same period last year, with new sales up 12% and resales up 23%… These buildings are central to the resident experience in our villages and provide the care, support and amenity our residents value. We're pleased with the level of interest and sales momentum across these villages' new buildings.

What's next for Summerset Group?

Summerset has reiterated its guidance for a development margin in the 20–25% long-term range, supported by the recent shift towards higher care and apartment sales. The company continues to manage construction in response to broader economic conditions and demand, with flexibility to adjust its build programme.

Investors can look forward to Summerset's half-year FY26 financial results scheduled for Thursday 27 August. Key milestones, including further progress at Australian sites, will also be closely watched.

Summerset Group Holdings share price snapshot

Over the past 12 months, Summerset Group shares have declined 28%, trailing the S&P/ASX 200 Index (ASX: XJO), which has risen 3% over the same period.

View Original Announcement

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

More on Healthcare Shares

A guy shrugs his shoulders, not sure which is the right decision.
Healthcare Shares

Cochlear shares are flying. Is this just the start?

Up 32% in a month, but can the ASX healthcare stock reach $300 again?

Read more »

Three health professionals at a hospital smile for the camera.
Healthcare Shares

2 ASX 200 healthcare shares to buy after sector rebounds 23% in a month

The rapid rebound in ASX 200 healthcare shares has caught many investors by surprise.

Read more »

A medical researcher in a white coat holds laboratory equipment and smiles.
Healthcare Shares

2 ASX healthcare shares crashing, now bouncing: buy, hold or sell?

With a 13% to 34% recovery over the past month, do experts believe it's sustainable?

Read more »

Man sleeping with a sleep apnoea mask on.
Broker Notes

Down 22%! 3 reasons to buy the big dip in ResMed shares today

Two leading analysts deliver their verdicts on ResMed’s beaten-down share price.

Read more »

Portrait, confidence and team of doctors in the hospital standing after a consultation or surgery. Success, healthcare and group of professional medical workers in collaboration at a medicare clinic.
Healthcare Shares

ASX healthcare shares have jumped 21% since June. Can the recovery continue?

Can ASX healthcare shares can sustain their recovery?

Read more »

Donor donates blood in medical clinic. Beautiful European woman of 30 years sits in medical chair looking into camera and smiling.
Healthcare Shares

After losing half their value, can CSL shares reclaim $275?

A rebound is here, but can it last? Here's what the experts think.

Read more »

A man wearing a white coat holds his hands up and mouth open with joy.
ASX Share Market News

Healthcare shares lead the ASX 200 again as sector rotation gathers pace

The sector is up 20% in just a month as value investors swoop on blue-chip favourites like CSL.

Read more »

A doctor shrugs and holds his hands out.
Healthcare Shares

CSL shares are up 25%: is it time to buy, hold or sell?

CSL's recovery could be well underway, but analysts remain far from convinced.

Read more »